Therapies using anti-angiogenic peptide mimetics of thrombospondin-1

Author： Henkin Jack   Volpert Olga V  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.12, 2011-12, pp. : 1369-1386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Angiogenic Therapies for Children with Cancer

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 879-889

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic therapies for malignant pleural mesothelioma

By Ceresoli Giovanni Luca   Zucali Paolo Andrea  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 6, 2012-06 ,pp. : 833-844

Informa Healthcare

Access to resources Recommend Favorite

Anti-Angiogenic Therapies in the Treatment of Waldenstrom's Macroglobulinemia

By  

Current Cancer Drug Targets, Vol. 11, Iss. 9, 2011-11 ,pp. : 1025-1029

Bentham Science Publishers

Access to resources Recommend Favorite

Current status and future prospects for anti-angiogenic therapies in cancer

By Staton Carolyn A   Brown Nicola J   Reed Malcolm WR  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 961-979

Informa Healthcare

Access to resources Recommend Favorite

Do anti-angiogenic cancer therapies increase risk of significant weight loss?

By Zhang Shuang   Yu Min   Wei Yuquan  

Expert Opinion on Drug Safety, Vol. 13, Iss. 4, 2014-04 ,pp. : 473-482

Informa Healthcare

Access to resources Recommend Favorite